INTRODUCTION
Ultraviolet (UV) phototherapy is used for a myriad of dermatologic conditions such as psoriasis and mycosis fungoides (MF). UV phototherapy is most commonly administered in an office setting, with ideal treatment typically consisting of several sessions per week.
While phototherapy is effective for many conditions, the time and expense of this treatment can be a burden and an obstacle [1] . Many patients live over one hundred miles from a dermatologist or have other time and resource limitations that make in-office phototherapy inaccessible. Therefore, in-office phototherapy may not be a pragmatic treatment option for many patients who could potentially benefit from it. Unsupervised sun exposure is a standard recommendation when in-office phototherapy is not feasible [2] . Commercial tanning facilities may offer another potential alternative means to access phototherapy, being both conveniently located and economically feasible. This can provide access to phototherapy to many patients who currently find treatment with in-office phototherapy to be cumbersome or impracticable. We examined available evidence for the use of commercial tanning facilities as a dermatologic treatment modality in diseases such as atopic dermatitis, acne, hand eczema, MF, vitiligo, and pruritus.
METHODS

Literature searches were done in PubMed in
February 2015 combining therapy descriptor keywords, such as ''tanning beds'' and ''phototherapy'', with dermatologic conditions known or believed to be sensitive to UV light, including ''psoriasis'', ''mycosis fungoides'', ''acne'', and ''atopic dermatitis''/''eczema''. No inclusion or exclusion dates were defined. From there, further articles were found using the reference sections of the initial papers. A similar methodology was used with the Google Scholar search engine. Additional information was sought with targeted searches in both PubMed and Google Scholar. In conditions that did not have studies using commercial tanning beds, we investigated the efficacy of UV radiation overlapping with the emission spectrum of tanning beds. Only articles in English and prospective studies were included in this review. This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors.
RESULTS
Characteristics of Indoor Tanning Light
The light used during indoor tanning is poorly defined. The US Food and Drug Administration does not specify limits on the power of UV light emissions, instead defining ''irradiance ratio limits'', where the ratio of irradiance between wavelengths of 200 and 260 nm to the irradiance between wavelengths 260 and 320 nm should not exceed 0.003 at any distance and direction from the source [3] .
While in the US there are state and federal regulations, according to a study performed in North Carolina, the extent to which commercial tanning facilities comply is poor, with only 1 out of 32 commercial tanning establishments within complete compliance of state and federal guidelines [4] .
The wavelengths of UVA and UVB irradiation from tanning beds are highly variable; however, tanning beds as a whole tend to emit primarily UVA irradiation. Rates of UVB emissions range from 0.5% to 5.0% in North Carolina tanning beds [4] . . Only 23.3% of tanning facilities were in compliance with maximal irradiances for both UVA and UVB spectra. Ninety-six percent of tanning bed devices were approved models, but only 74% of lamps in these tanning beds were an approved type. The maximum erythemaweighted UV irradiance varied by up to a factor of 2 for the same tanning bed devices in different facilities, due to the difference in lamps used. Additionally, within each facility, irradiance measures varied by up to a factor of two, due to the different tanning bed devices [7] . The variety of tanning bed devices and lack of standardization of lamps within these devices present a therapeutic hurdle to recommending their use as a treatment for skin disease.
Efficacy of Tanning Beds
While different tanning beds emit variable amounts of UVB and UVA (varying in both the absolute flux and the ratio of UVB to UVA), there is extensive in vitro evidence that both UVA and UVB have anti-inflammatory effects (Tables 1, 2 ).
Risks of Tanning
As with any UV light-based therapies, there are potential risks of using tanning beds as treatment (Table 3) . There is a link between artificial UV light exposure and an increased risk of developing skin cancer. In 2006, a metaanalysis showed an increased risk of developing melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) in patients who have ever used a tanning bed compared with those who have never tanned with artificial UV light [8] . A particularly large increase in melanoma risk was found when comparing those who ever tanned before age 35 years to those who had never used an indoor tanning device. A subsequent study found a dose/response relationship between artificial UV light exposure and increasing risk of melanoma, with those having tanned 10 times or fewer having only a 34% increased risk of developing a melanoma, compared to 272% in those patients who have used indoor tanning beds over 100 times [9] . In a more recent study, an association was found between age of first tanning bed exposure and increased risk of melanoma in patients with more than 10 tanning bed exposures [10] . A large prospective study found no association between age range of most frequent tanning bed use and risk of melanoma or SCC, but did find an even greater risk of BCC in women who visited tanning beds most frequently during their high school and college years compared to those who visited most frequently during age 25-35 years, both of which were greater than the risk in women who had never used a tanning bed [11] . This was further supported by findings that a dose/response relationship can be found between the risk of developing a BCC and increasing numbers of tanning sessions, hours spent indoor tanning, years spent indoor tanning, number of burns at the biopsy site, and number of burns associated with indoor tanning [12] . This study also found a strong relationship with artificial UV light exposure and truncal BCCs, as compared to the head and neck, indicating a possible increases susceptibility of bodily areas that receive less incidental solar irradiation [12] . Furthermore, UVB UVB depletes of LC, the major antigen-presenting cell of the skin, through migration of damaged LCs to regional lymph nodes and through direct apoptosis. UVB exposed LCs preferential present antigens to Th2 and do not stimulate Th1. UVB irradiation induces T-suppressor and immunotolerant macrophages in the epidermis [62] Suppression of ICAM-1 expression by keratinocytes associated with a significant increase in intracellular thymine dimers in vivo with restoration of ICAM-1 expression via topical DNA repair enzyme [63] Both CGRP is released from cutaneous nerves after xposure to UVR, increasing cAMP levels in T cells, inhibiting T cell proliferation and inhibiting the production of IL-2 and expression of TNF-a, TNF-b and IFN-c. CGRP also causes mast cells to degranulate and release TNF-a, which can interfere with APC's ability to initiate the inflammatory cascade [64] The UV-induced mast cell degranulation releases the anti-inflammatory cytokine IL-10. UV irradiation damages keratinocyte DNA, activating p53 and subsequently increasing the transcription of POMC, which itself induces further production of IL-10 [65] Stimulates HDMEC to produce a-melanocyte-stimulating hormone, inhibiting expression of the adhesion molecules VCAM-1 and E-selectin, inhibiting the extravasation of leukocytes during inflammation [64] PUVA Induces cell death by inducing DNA damage, initiating a delayed apoptotic cascade [66] APC antigen-presenting cell, CGRP calcitonin gene-related peptide, HDMEC human dermal microvascular endothelial cells, HO-1 heme oxygenase, ICAM-1 intracellular adhesion molecule 1, IFN Interferon, IL interleukin, LC langerhans cells, POMC proopiomelanocortin, PUVA psoralen ultraviolet A, Th1 type 1 T cells, Th2 Type 2 T cells, TNF tumor necrosis factor, UV ultraviolet, UVR ultraviolet radiation, VCAM-1 vascular cell adhesion molecule 1 
Tanning and Conditions Treated by Phototherapy
Psoriasis
Assessing the evidence for commercial tanning facilities as a treatment for psoriasis is important as indoor tanning is already commonly used by people as a psoriasis treatment, perhaps the most frequently used form of phototherapy for psoriasis. One center reported that more than 50% of patients presenting to their clinic had tried or were currently treating their psoriasis with commercial tanning sessions [14] . Another survey found that 36% of patients reported having tried commercial tanning beds as a psoriasis treatment [15] .
There may be concern that tanning beds that emit primarily UVA would not be effective for the treatment of psoriasis. While one study With minimal erythemal dosing of UVA light noted to be 10-100 J/cm 2 [16] commercial tanning beds could be used to deliver therapeutic doses of UVA light in the treatment of cutaneous T cell lymphoma, though we found no reported cases of this therapeutic approach.
Vitiligo
Many UV-based therapies are employed when treating vitiligo, including PUVA, NB-UVB (both in office and home units) and excimer laser, along with adjuvant treatments such as topical calcineurin inhibitors and topical corticosteroids [41] [42] [43] [44] . One study found that broadband UVB phototherapy was superior to NB-UVB in treating vitiligo, which suggests that tanning beds would also be effective [45] . Sun exposure induces repigmentation of vitiligo lesions during the summer in many patients [46] . While there is a possibility of using commercial tanning beds to deliver therapeutic doses of UV light to patients with vitiligo, we did not find clinical trials assessing this potential use.
Pruritus
The pathophysiology of itch is still being elucidated, and the mechanism by which UV light reduces pruritus is not well defined. Given the relative lack of penetration of UVB through the epidermis, the effect of UVB is thought to be through its action on epidermal keratinocytes and Langerhans cells. The effects of UVA light are generally believed to be dermal in origin, affecting lymphocytes, mast cells, and fibroblasts [47] . Dermal Schwann cells and perineural cells degenerate after exposure to UVA light as well [48] .
UVB light has been successfully employed in the treatment of uremic pruritus for decades.
Early studies demonstrated the efficacy of broadband UVB, with 9 out of 10 patients experiencing a significant reduction in pruritus [49] . NB-UVB is also effective [50, 51] . There are several theories on the mechanism of UVB light in the treatment of uremic pruritus, including UVB-induced reduction in skin phosphorus, leading to decreased microprecipitation of divalent cations with phosphorous in the skin and UVB-induced mast cell apoptosis [52, 53] .
There may be a systemic effect of UV on uremic itch, as patients treated unilaterally with UVB light report a reduction in pruritus on both sides of their body [54] .
HIV pruritus can be treated with either UVB or PUVA [55, 56] . And while in vitro and animal studies on the safety of UV light therapy raise concerns about induction of viral replication, these safety concerns have not shown up in vivo, and reviews of the literature have endorsed UV light therapy as safe in this setting [57, 58] . However, we found no data on the potential use of commercial tanning beds in the treatment of HIV-associated pruritus.
DISCUSSION
Many skin conditions are responsive to office phototherapy, however, office phototherapy can be expensive and inconvenient. Home A significant concern for use of commercial tanning facilities in phototherapy is their considerable variability in emission make up and dosing. Variability in exposure can be reduced by selecting a single bed, with additional caution/dose reduction when bulbs are changed; doing so may provide more predictable dosimetry than is obtainable with sun exposure. For psoriasis treatment, 3-5 sessions per week for 6 weeks with 4.6% UVB tanning lamps was effective (Table 4) [19]. The length of the sessions was based upon selfreported skin type and the manufacturer's suggestions for the particular bulb used in that study. For patients on an oral retinoid, a starting dose of 2-3 min with 1 min incremental increases (30 min maximum), 5-7 times a week was safe in a single study that used a 4.7% UVB output commercial tanning unit (Table 5) [24]. Because of the variability between different tanning beds, these data can give only a limited reference point for dosing; starting with a low dose and increasing slowly as tolerated would be prudent.
Given the variability demonstrated in the UV output of indoor tanning devices, we recommend some practical safety tips (Table 5) Table 2 ). The evidence for the use of commercial tanning, with its clear doseresponse effect [18] , is as strong as or stronger than for sun exposure, which lacks demonstration of a dose-response effect [59] .
Moreover, dosimetry can be better controlled with the use of indoor tanning when compared to exposure to natural sunlight, which can vary greatly based on geographical location, weather conditions, and the time of day and year [59] .
The National Psoriasis Foundation [2] recommends natural sunlight as a potential treatment for psoriasis. Considering this, recommending the use of tanning beds as a potential treatment may be just as reasonable.
CONCLUSIONS
While the use of tanning beds may not be right for every patient, in some patients the benefits of tanning beds as a source of UV therapy for their dermatological disease may be beneficial. Whether physicians recommend commercial tanning bed use or not, patients are likely to try it. In one study, nearly a third of male patients with psoriasis and nearly half of female patients with psoriasis reported having tried tanning as a treatment [15] . Withholding information on how to best use tanning may not be in our patients' best interest. While tanning beds carry the possibility for significant side effects, their benefits and risks should be weighted just as with any treatment or medication.
Furthermore, the risks of treatments that would be used as an alternative to tanning beds should also be considered, as many medications, such as methotrexate, carry the risk of severe side effects. Although there are significant risks associated with tanning beds, completely discounting its use may be a disservice to patients who have poor access to in-office and home phototherapy. 
